Cargando…
Machine learning approaches to drug response prediction: challenges and recent progress
Cancer is a leading cause of death worldwide. Identifying the best treatment using computational models to personalize drug response prediction holds great promise to improve patient’s chances of successful recovery. Unfortunately, the computational task of predicting drug response is very challengi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296033/ https://www.ncbi.nlm.nih.gov/pubmed/32566759 http://dx.doi.org/10.1038/s41698-020-0122-1 |
_version_ | 1783546763563499520 |
---|---|
author | Adam, George Rampášek, Ladislav Safikhani, Zhaleh Smirnov, Petr Haibe-Kains, Benjamin Goldenberg, Anna |
author_facet | Adam, George Rampášek, Ladislav Safikhani, Zhaleh Smirnov, Petr Haibe-Kains, Benjamin Goldenberg, Anna |
author_sort | Adam, George |
collection | PubMed |
description | Cancer is a leading cause of death worldwide. Identifying the best treatment using computational models to personalize drug response prediction holds great promise to improve patient’s chances of successful recovery. Unfortunately, the computational task of predicting drug response is very challenging, partially due to the limitations of the available data and partially due to algorithmic shortcomings. The recent advances in deep learning may open a new chapter in the search for computational drug response prediction models and ultimately result in more accurate tools for therapy response. This review provides an overview of the computational challenges and advances in drug response prediction, and focuses on comparing the machine learning techniques to be of utmost practical use for clinicians and machine learning non-experts. The incorporation of new data modalities such as single-cell profiling, along with techniques that rapidly find effective drug combinations will likely be instrumental in improving cancer care. |
format | Online Article Text |
id | pubmed-7296033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-72960332020-06-19 Machine learning approaches to drug response prediction: challenges and recent progress Adam, George Rampášek, Ladislav Safikhani, Zhaleh Smirnov, Petr Haibe-Kains, Benjamin Goldenberg, Anna NPJ Precis Oncol Review Article Cancer is a leading cause of death worldwide. Identifying the best treatment using computational models to personalize drug response prediction holds great promise to improve patient’s chances of successful recovery. Unfortunately, the computational task of predicting drug response is very challenging, partially due to the limitations of the available data and partially due to algorithmic shortcomings. The recent advances in deep learning may open a new chapter in the search for computational drug response prediction models and ultimately result in more accurate tools for therapy response. This review provides an overview of the computational challenges and advances in drug response prediction, and focuses on comparing the machine learning techniques to be of utmost practical use for clinicians and machine learning non-experts. The incorporation of new data modalities such as single-cell profiling, along with techniques that rapidly find effective drug combinations will likely be instrumental in improving cancer care. Nature Publishing Group UK 2020-06-15 /pmc/articles/PMC7296033/ /pubmed/32566759 http://dx.doi.org/10.1038/s41698-020-0122-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Article Adam, George Rampášek, Ladislav Safikhani, Zhaleh Smirnov, Petr Haibe-Kains, Benjamin Goldenberg, Anna Machine learning approaches to drug response prediction: challenges and recent progress |
title | Machine learning approaches to drug response prediction: challenges and recent progress |
title_full | Machine learning approaches to drug response prediction: challenges and recent progress |
title_fullStr | Machine learning approaches to drug response prediction: challenges and recent progress |
title_full_unstemmed | Machine learning approaches to drug response prediction: challenges and recent progress |
title_short | Machine learning approaches to drug response prediction: challenges and recent progress |
title_sort | machine learning approaches to drug response prediction: challenges and recent progress |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296033/ https://www.ncbi.nlm.nih.gov/pubmed/32566759 http://dx.doi.org/10.1038/s41698-020-0122-1 |
work_keys_str_mv | AT adamgeorge machinelearningapproachestodrugresponsepredictionchallengesandrecentprogress AT rampasekladislav machinelearningapproachestodrugresponsepredictionchallengesandrecentprogress AT safikhanizhaleh machinelearningapproachestodrugresponsepredictionchallengesandrecentprogress AT smirnovpetr machinelearningapproachestodrugresponsepredictionchallengesandrecentprogress AT haibekainsbenjamin machinelearningapproachestodrugresponsepredictionchallengesandrecentprogress AT goldenberganna machinelearningapproachestodrugresponsepredictionchallengesandrecentprogress |